Athanasios Manolis
Overview
Explore the profile of Athanasios Manolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
3869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manolis A, Karakasis P, Patoulias D, Doumas M, Kallistratos M, Thomopoulos C, et al.
High Blood Press Cardiovasc Prev
. 2024 Oct;
32(1):7-31.
PMID: 39467996
Aims: To systematically appraise and summarize the available evidence from published randomized controlled trials considering the effect of nebivolol on blood pressure in patients with hypertension. Methods: Literature search was...
2.
Mottolese N, Coiffard O, Ferraguto C, Manolis A, Ciani E, Pietropaolo S
Autism Res
. 2024 Sep;
17(9):1742-1759.
PMID: 39234879
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a neurodevelopmental disease caused by mutations in the X-linked CDKL5 gene and characterized by early-onset epilepsy, intellectual disability, and autistic features. To...
3.
Sukonthasarn A, Borghi C, Chan Y, Cheng F, Choi H, Mehta R, et al.
Eur J Intern Med
. 2024 Jul;
127:25-30.
PMID: 38960822
Hypertension remains a major problem worldwide, especially across the Asia-Pacific region, which reports high prevalence rates and slow improvements in treatment rate and blood pressure (BP) control rate. Asian patients...
4.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
Blood Press
. 2024 Jun;
33(1):2368800.
PMID: 38910347
Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A...
5.
Menti A, Kollias A, Papadakis J, Kalaitzidis R, Milionis H, Krokidis X, et al.
Hellenic J Cardiol
. 2024 Jun;
PMID: 38823778
Objective: The COVID-19 pandemic had an adverse impact on several cardiovascular risk factors. This study investigated the prevalence, awareness and treatment of hypertension in Greece before and after the pandemic....
6.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
J Hypertens
. 2024 May;
42(9):1544-1554.
PMID: 38747416
Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management...
7.
Manolis A, Kallistratos M, Poulimenos L, Thomopoulos C
Am J Med Sci
. 2023 Dec;
367(3):155-159.
PMID: 38072070
The vast majority of antianginal drugs decrease heart rate and or blood pressure levels or the inotropic status of the left ventricle to decrease myocardial oxygen consumption (MVO2) and thus...
8.
Olszowka M, Hagstrom E, Hadziosmanovic N, Ljunggren M, Denchev S, Manolis A, et al.
Int J Cardiol
. 2023 Sep;
394:131395.
PMID: 37748524
Background: Sleep-related breathing disorders (SRBD) are related to cardiovascular outcomes in patients with chronic coronary syndrome (CCS). Whether SRBD-related symptoms are associated with prognostic biomarkers in patients with CCS is...
9.
Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al.
J Hypertens
. 2023 Jun;
41(12):1874-2071.
PMID: 37345492
Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici (Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luís Bronze (Portugal), John Chalmers (Australia), Tine De Backer (Belgium), Alejandro de la Sierra (Spain),...
10.
Anastasiadis F, Antoniadis D, Chountis D, Mantas I, Lekakis I, Elisaf M, et al.
Hellenic J Cardiol
. 2023 Feb;
72:24-33.
PMID: 36746373
Background: In light of the scarcity of evidence, TIGREECE evaluated the clinical management and long-term outcomes of patients at high risk for an atherothrombotic event who have suffered a myocardial...